Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 1/20 | 0.51 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.48 |
| ▸ | GPR142 | Q7Z601 | 1/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.48 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 4/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.44 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.44 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.44 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL996805 | 0.92 | PDGFRB (0.48) | KDRPDGFRBGPR142PDE10ASMN1; SMN2 | |
| SCHEMBL1079094 | 0.85 | NPC1 (0.60) | PDGFRBSMN1; SMN2MAPTNPC1RAB9A | |
| SCHEMBL998095 | 0.85 | NPC1 (0.50) | KDRPDGFRBPDE10AFAAHLMNA | |
| SCHEMBL1818123 | 0.83 | NPC1 (0.58) | PDGFRBGPR142TRPV1SMN1; SMN2FAAH | |
| SCHEMBL1820659 | 0.78 | TRPV1 (0.48) | KDRPDGFRBGPR142TRPV1PDE10A | |
| Hydrochloric Acid SCHEMBL1819216 | 0.78 | TRPV1 (0.47) | KDRPDGFRBGPR142TRPV1PDE10A | |
| SCHEMBL17635116 | 0.75 | PDGFRB (0.71) | KDRPDGFRBTRPV1CYP3A4SMN1; SMN2 | |
| SCHEMBL23326841 | 0.72 | RAB9A (0.70) | PDGFRBSMN1; SMN2MAPTNPC1RAB9A | |
| SCHEMBL2803952 | 0.71 | TRPV1 (0.56) | GPR142TRPV1CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL25240416 | 0.70 | GPR142 (0.60) | PDGFRBGPR142TRPV1CYP2D6SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1637521-B1 | NOVEL TRICYCLIC HETEROCYCLE COMPOUND | ONO PHARMACEUTICAL CO (JP) | 2013-06-19 | — | — | EP | disclosed |
| WO-2011060394-A1 | COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS | SCHERING CORPORATION (US) | 2011-05-19 | — | — | WO | disclosed |
| WO-2011060395-A1 | CYCLIC UREAS USEFUL AS HIV INHIBITORS | SCHERING CORPORATION (US) | 2011-05-19 | — | — | WO | disclosed |
| US-7872133-B2 | Tricyclic heterocycle compound | ONO PHARMACEUTICAL CO., LTD. (JP) | 2011-01-18 | — | — | US | disclosed |
| US-20060154944-A1 | Novel tricyclic heterocycle compound | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-07-13 | — | — | US | disclosed |
| EP-1637521-A1 | NOVEL TRICYCLIC HETEROCYCLE COMPOUND | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060154944-A1 | Novel tricyclic heterocycle compound | CYP11B1, CYP11B2, HCCS | KDR 4789/4885PDGFRB 4439/4885GPR142 2079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.